The recent Harvard research funding freeze has sent shockwaves through the academic community, leaving researchers scrambling to navigate the repercussions.This abrupt halt, issued shortly after Harvard rejected demands from the Trump administration, targets key projects at the Wyss Institute, particularly those innovative organ-on-a-chip technologies led by Don Ingber.